Intra-vaginal device and method for sustained drug release
Patent 4983393 Issued on January 8, 1991. Estimated Expiration Date: 
October 14, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
October 14, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 2110962 3429308 3432594 Intravaginal contraceptive and drug release device and method for making and using same Bioerodible diaphragm Diagnosing cancer by observing marker glycosaminoglycans extracted from patient Biodegradable matrix and methods for producing same Patent #: 4703108 InventorsAssigneeApplicationNo. 257156 filed on 10/14/1988US Classes:424/430, Vaginal, urethral, uterine424/426, Errodable, resorbable, or dissolving424/432, IUD or ring424/433, Depot, pellet, matrix, or suppository424/484, Matrices424/488Polysaccharides (e.g., cellulose, etc.)ExaminersPrimary: Cashion, Merrell C. Jr.Assistant: Spear, James M. Attorney, Agent or FirmInternational ClassA61K 009/02AbstractThe invention disclosed provides an intra-vaginal device prepared using ingredients which slowly release in the vagina over a significant period of time. The present intra-vaginal device also usefully serves as a drug release means for controllably releasing a drug in the vagina. A method for controlled drug release in the vagina is also disclosed. | |
